CLEARONE INC annual report, FY2019

ClearOne, Inc. FY2019 Form 10-K Summary

Business Context and Reporting Period

ClearOne designs and sells conferencing, collaboration, professional microphone, video collaboration, and AV networking solutions through distributors, resellers, integrators, and selected direct channels. The filing covers the fiscal year ended December 31, 2019, with comparisons to fiscal 2018; it is an annual filing rather than a quarterly report.

  • 2019 revenue mix: audio conferencing 46.3%, microphones 35.2%, and video products 18.4%.
  • Sales were generated 54% in the United States and 46% outside the United States.
  • The Company had 127 full-time employees and sold through approximately 345 distributors and direct resellers in approximately 61 countries.

Financial Performance and Position

Metric20192018Change
Revenue$25.0 million$28.2 millionDown 11%
Gross profit$11.2 million$13.4 millionDown 16%
Gross margin45%47%Down 2 percentage points
Operating loss$8.6 million$10.3 millionImproved 17%
Net loss$8.4 million$16.7 millionImproved 50%
Basic and diluted loss per share$0.51 loss$1.87 lossImproved
Cash used in operating activities$4.7 million$6.6 millionImproved by $2.0 million
  • Audio conferencing revenue declined 17% to $11.6 million; microphone revenue declined 2% to $8.8 million; and video revenue declined 11% to $4.6 million.
  • Operating expenses decreased 17% to $19.8 million, including sales and marketing expense of $7.9 million and research and development expense of $5.8 million. General and administrative expense increased slightly to $6.0 million.
  • The income tax provision fell to $56,000 from $6.4 million in 2018, primarily because the prior-year results included a large change in the valuation allowance on deferred tax assets. The Company maintained a full valuation allowance and reported no net deferred tax assets at year-end.
  • Cash and cash equivalents were $4.1 million at December 31, 2019, compared with $11.2 million at December 31, 2018. Marketable securities totaled $4.5 million, producing cash and marketable securities of approximately $8.6 million.
  • Working capital declined to $18.9 million from $28.4 million. Total inventory declined to $17.7 million from $22.2 million, but $6.3 million remained classified as long-term inventory.
  • Total assets were $55.1 million and shareholders’ equity was $44.5 million at year-end.
  • The Company capitalized $5.1 million of patent-defense costs during 2019. Capitalized patent-defense costs, net of amortization, were approximately $11.0 million within intangible assets.

Debt, Liquidity, and Capital Resources

  • On December 17, 2019, ClearOne issued $3.0 million of secured convertible notes and warrants to purchase 340,909 shares to affiliate Edward D. Bagley. Net proceeds were approximately $2.7 million.
  • The notes mature December 17, 2023, bear interest at a variable rate, are initially convertible at $2.11 per share, and are secured by a first-priority lien on the Company’s assets. The warrants have an initial exercise price of $1.76 per share and expire December 17, 2026.
  • The notes had a net carrying amount of $2.2 million at December 31, 2019. Contractual obligations totaled $6.8 million, including $3.0 million of note principal, $3.0 million of operating lease obligations, and $0.8 million of purchase commitments.
  • Management stated that available resources and expected inventory reductions should provide liquidity through at least March 31, 2021, but acknowledged that additional financing may be required and may not be available on acceptable terms.
  • The dividend program remains suspended, and the share repurchase program has expired.

Material Changes Versus 2018

  • Revenue declined across all major product groups and most geographic markets, with the largest declines in the Americas and Europe and Africa.
  • Management attributed the revenue pressure primarily to alleged competitor infringement of ClearOne patents in audio conferencing and microphones, increased video competition, and reduced partner attention.
  • Gross margin declined because of higher material costs and inventory obsolescence, partly offset by lower overhead.
  • Cost reductions lowered sales and marketing expense by 20% and research and development expense by 26%.
  • Operating and net losses improved mainly because of lower operating expenses and substantially lower tax expense.
  • Cash declined by $7.1 million during 2019 despite lower operating cash use, primarily because of $5.1 million of capitalized patent-defense costs and changes in marketable securities.
  • The Company adopted the new lease standard in 2019, recognizing approximately $3.0 million of right-of-use assets and $3.1 million of lease liabilities without a material income-statement impact.
  • Management concluded that the material weakness identified in the 2017 audit had been remediated and that internal control over financial reporting was effective as of December 31, 2019.

Outlook, Risks, Contingencies, and Unusual Items

  • No formal numerical revenue or earnings guidance is provided. Management expects product innovation, cost reduction, intellectual-property enforcement, cloud collaboration products, and new microphone products to support a return to growth, but provides no assurance.
  • ClearOne is engaged in extensive patent litigation with Shure. In August 2019, a preliminary injunction restricted Shure’s MXA910 ceiling microphone sales for a specified drop-ceiling configuration. ClearOne also faces Shure’s claims concerning ClearOne’s BMA CT product. Litigation outcomes remain uncertain and could materially affect cash flows, earnings, and intangible assets.
  • The Company spent approximately $13.6 million on patent litigation from 2016 through 2019 and expects additional costs. Adverse litigation developments could require partial or full write-off of capitalized legal costs.
  • COVID-19 had curtailed manufacturing and workplace activities beginning March 23, 2020. The Company stated that it had not received significant customer cancellations as of the filing, but acknowledged that restrictions on gatherings, supply-chain disruption, and broader economic effects could materially harm demand, operations, financial condition, and cash flows.
  • Key ongoing risks include intense competition, rapid technological change, demand-forecasting errors, distributor concentration, long-term and potentially obsolete inventory, outsourced manufacturing with limited secondary sources, tariffs and supply-chain disruption, international operations, customer credit risk, and the need for additional financing.
  • One distributor represented approximately 10.7% of 2019 revenue, creating some customer concentration risk.

Investor Verification Checklist

  • Verify the sustainability of cash resources, the stated liquidity runway, and the availability and terms of any future financing.
  • Review the secured note terms, affiliate relationship with Mr. Bagley, potential conversion dilution, warrant dilution, and collateral provisions.
  • Track the Shure litigation, preliminary injunction enforcement, PTAB proceedings, potential damages, legal spending, and recoverability of capitalized patent-defense costs.
  • Assess whether the $6.3 million of long-term inventory can be sold at or above carrying value without additional write-downs.
  • Evaluate whether new products, including BMA CT, COLLABORATE Live, COLLABORATE Space, and Versa solutions, can reverse the revenue decline.
  • Monitor COVID-19 effects on manufacturing, distributors, customer demand, workplace activity, and large-installation environments.
  • Confirm continued effectiveness of internal controls and monitor for any recurrence of material weaknesses.